• PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in China

    Nov 1, 2011, 00:00

  • PMS68 Measuring the Health-Related Quality of Life in Patients with Rheumatoid Arthritis Treated with Adalimumab in Gree Comparing the Results of One Generic (EQ-5D) and One Disease-Specific (HAQ) Instrument

    Nov 1, 2011, 00:00

  • PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PSU14 Complications and Costs Associated with Tubal Ligations

    Nov 1, 2011, 00:00

  • PR2 Value-Based Pricing in the UK- Developing an Evaluation Framework for Burden of Illness

    Nov 1, 2011, 00:00

  • PIH66 Trait or State- An Exploration of Self-Esteem, Happiness and Quality of Life by Time Series

    Nov 1, 2011, 00:00

  • RS4 The Interim Cancer Drugs Fund - How To Not Spend £50 Million

    Nov 1, 2011, 00:00

  • PCN77 Cost-Effectiveness of Granulocyte Colony Stimulating Factor (G-CSF) in Primary (PP) and Secondary Prophylaxis (SP) of Febrile Neutropenia (FN) in Patients with Stages 2 and 3 Breast Cancer (BC) Undergoing Cytotoxic Chemotherapy in Fra ...

    Nov 1, 2011, 00:00

  • PDB63 Anti-Diabetic Therapeutic Strategies for Type 2 Diabetes Patients with Chronic Kidney Disease in France

    Nov 1, 2011, 00:00

  • PCV118 Observational Study on the Treatment, Cost and Quality of Life of Subjects with Hereditary Angioedema

    Nov 1, 2011, 00:00

  • PGI21 Cost-Effectiveness of Peginterferon and Ribavirin for Elderly Patients with Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registration in Japan

    Nov 1, 2011, 00:00

  • PCN47 Clinical and Economic Burden of Breast Cancer in Japan- A Diagnosis Procedure Combination–Based Claims Database Survey

    Nov 1, 2011, 00:00

  • PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States

    Nov 1, 2011, 00:00

  • PIH61 A qualitative Evaluation of the Integrated Management of Childhood Illness (IMCI) in Northeastern Brazil and Peru- The Managers' Perspective

    Nov 1, 2011, 00:00

  • HG3 Cost Comparisons and Methodological Heterogeneity in Cost-of-Illness Studies- The Example of Colorectal Cancer

    Nov 1, 2011, 00:00

  • PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated Endpoints

    Nov 1, 2011, 00:00

  • PDB31 Cost of Diabetes in Croatia Impact of Complications on the Costs of Type II Diabetes

    Nov 1, 2011, 00:00

  • PCN160 Prostate Cancer Screening Practices in the Republic of Ireland- The Determinants of Uptake

    Nov 1, 2011, 00:00

  • PCN71 Value of Progression-Free Survival (PFS) in Refractory Non-Small Cell Lung Cancer (NSCLC)- An Exploratory Modeling Analysis

    Nov 1, 2011, 00:00

  • PMH26 Direct Cost of Schizophrenia in Quebec, Canada- An Incidence-Based Microsimulation Monte-Carlo Markov Model

    Nov 1, 2011, 00:00

  • PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)

    Nov 1, 2011, 00:00

  • PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community- The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, Ghana

    Nov 1, 2011, 00:00

  • PCN178 Reimbursement of Cancer Drugs in the UK- New Approach to End-of-Llife Treatments and the Technology Appraisal Programme of NICE

    Nov 1, 2011, 00:00

  • PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece

    Nov 1, 2011, 00:00

  • PHP17 Characteristics of High Cost Ambulatory Drugs in French Health Care System

    Nov 1, 2011, 00:00

  • PRM52 Socioeconomic Patterns Among International Immigrants in Chile- The Use of Clusters

    Nov 1, 2011, 00:00

  • PCV100 Resource Use in Patients with Acute Coronary Syndrome - an Observational Study Across Secondary and Primary Care in a UK Population

    Nov 1, 2011, 00:00

  • PUK1 Belatacept Versus Tacrolimus- Results of an Indirect Analysis from a Systematic Review of Immunosuppressive Therapies for Kidney Transplant Recipients

    Nov 1, 2011, 00:00

  • PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in Brazil

    Nov 1, 2011, 00:00

  • PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

    Nov 1, 2011, 00:00

  • PRS71 Evaluation of the Getquit Clinics for Smoking Cessation

    Nov 1, 2011, 00:00

  • PCN44 Cost-of-Illness Study of Human Papillomavirus Cancers in England

    Nov 1, 2011, 00:00

  • PSY8 Two Analgesic Techniques After Cesarean DELIVERY- A COST-Effectiveness Analysis Study

    Nov 1, 2011, 00:00

  • PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada

    Nov 1, 2011, 00:00

  • PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?

    Nov 1, 2011, 00:00

  • PHP20 Economic Evaluation of Poison Control Centers- A Systematic Review

    Nov 1, 2011, 00:00

  • PSS35 Validation of the Eighteen Item Functional Assessment of Visual Tasks (Vistas-18) Using A New Lens Prescription Methodology

    Nov 1, 2011, 00:00

  • PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation Program

    Nov 1, 2011, 00:00

  • PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in Bulgaria

    Nov 1, 2011, 00:00

  • PCN69 Cost-Effectiveness Analysis of Rituximab Maintenance Treatment of Follicular Lymphoma in Patients Responding to First-Line Inmunochemotherapy Induction

    Nov 1, 2011, 00:00

  • PIH40 Designing a Disease-Specific Patient Reported Outcome (PRO) for a Rare Disease- Assessing the Reliability, Validity, and Responsiveness of the Hunter Syndrome - Functional Outcomes for Clinical Understanding Scale (HS-Focus)

    Nov 1, 2011, 00:00

  • PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMD12 Economic Impact analysis of Sterilization of Rigid Endoscopes with Sterradtm versus Steam in Spain

    Nov 1, 2011, 00:00

  • DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control- A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation Model

    Nov 1, 2011, 00:00

  • PRS5 Analysis Of Efficacy and Safety of Dornase Alfa in The Treatment of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or Hemodialysis

    Nov 1, 2011, 00:00

  • PRS25 Systematic Literature Review of Economic and Humanistic Burden of Dyspnoea in COPD

    Nov 1, 2011, 00:00

  • PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in Australia

    Nov 1, 2011, 00:00

  • PIN66 Cost of Virologic Failure with Etravirine and Raltegravir in the Brazilian National AIDS Program

    Nov 1, 2011, 00:00

  • PND54 Quality of Life Impairment, Disability, and Economic Burden Associated with Chronic Daily Headache Focussing on Chronic Migraine With or Without Medication Overuse- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN5 Efectividad CLÍnica Y Costo-Efectividad Del Tratamiento De Segunda LÍnea Para Carcinoma MetastÁsico De CÉlulas Renales

    Nov 1, 2011, 00:00

  • PCV6 Comparison of Bleeding Rates between Statin and Statin-Free Patients on Warfarin- A Claims Database Approach

    Nov 1, 2011, 00:00

  • PND40 A Study to Estimate Utility Values for Different Levels of Severity of Migraine Pain

    Nov 1, 2011, 00:00

  • PCN4 Effect of Antiemetic Prophylaxis Against Chemotherapy-Induced Nausea and Vomiting with 5-HT3 Receptor Antagonists in Patients with Lymphoma

    Nov 1, 2011, 00:00

  • PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pi ...

    Nov 1, 2011, 00:00

  • PCN200 Using A Weibull Parametric Model for Failure-Time Data to Assess Progression-Free Survival as A Surrogate Endpoint for Overall Survival in A Trial of Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2011, 00:00

  • CV2 Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the Private Sector in México

    Nov 1, 2011, 00:00

  • PHP109 Tendering of Biosimilars in the UK – Does Launch Price Actually Matter?

    Nov 1, 2011, 00:00

  • PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia

    Nov 1, 2011, 00:00

  • PMS40 Economic Evaluation of Etanercept in Rheumatoid Arthritis from the Public Payer perspective in Brazil

    Nov 1, 2011, 00:00

  • PCV138 Using a Population- Based, Budget- Constrained, Cost-Effectiveness Model to Assess the Health and Economic Impacts of Using Statins for Primary Prevention Based on the Jupiter Trial intended Use Population

    Nov 1, 2011, 00:00

  • PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway

    Nov 1, 2011, 00:00

  • PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En México

    Nov 1, 2011, 00:00

  • PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in Germany

    Nov 1, 2011, 00:00

  • PRM14 Mondriaan- A Dutch 'Population' Laboratory

    Nov 1, 2011, 00:00

  • PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community Pharmacies

    Nov 1, 2011, 00:00

  • PDB48 SHORT-Term Cost-Effectiveness of Insulin Detemir Versus NPH Insulin in Insulin-Naïve Subjects with Type 2 Diabetes in Sweden

    Nov 1, 2011, 00:00

  • PMS4 Economic Evaluation of Post-Operation orthopedic Surgery of antacid, antihemetic and analgesic Medication after Ketoprophene, Ketorolac, Parecoxib and Tenoxicam in Brazilian Patients

    Nov 1, 2011, 00:00

  • PCN6 Evaluacion Economica Del Dasatinib En El Tratamiento De La Leucemia Mieloide Cronica En Pacientes Resistentes Al Imatinib En Chile

    Nov 1, 2011, 00:00

  • PHP166 On-Going Market Access Advice A Possible solution to Help Ensure Long-Term Success in Post-Marketing Clinical Studies- Cross Functional Teams or External Consultation?

    Nov 1, 2011, 00:00

  • PHP16 Waiting Time and Its Implications on the Utilization of Antenatal Services in A Free Service Provision Setting in the Asante Akim North Municipal, Ghana

    Nov 1, 2011, 00:00

  • PCV64 the Potential Clinical and Economic Outcomes of Pharmacogenetic-Oriented Warfarin Therapy in Russia

    Nov 1, 2011, 00:00

  • PCV45 Health Economic Evaluation of Ticagrelor in Patients with Acute Coronary Patients (ACS) Based on the Plato Study from A Spanish Health Care Perspective

    Nov 1, 2011, 00:00

  • PCN158 The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic Testing

    Nov 1, 2011, 00:00

  • PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study

    Nov 1, 2011, 00:00

  • PHP98 Exploring Regional Variation in Tariffs/Public Prices Across Autonomous Communities in Spain- The Case of Diagnosis Related Groups and ICD-9 Diagnostic Codes

    Nov 1, 2011, 00:00

  • PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder- Indirect Comparisons at Twelve Weeks

    Nov 1, 2011, 00:00

  • PMD82 Drug Eluting Balloon for the Treatment of peripheral Artery Disease- A Cost-Effectiveness analysis in Italy

    Nov 1, 2011, 00:00

  • PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus- Evidence from a Dutch Cohort

    Nov 1, 2011, 00:00

  • PGI3 Current Treatments for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2011, 00:00

  • PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)

    Nov 1, 2011, 00:00

  • PCN4 Costo-Efectividad De Octreotide Comparado Con Terapia De Soporte Usual Para El Tratamiento De Tumores Neuroendocrinos En Colombia

    Nov 1, 2011, 00:00

  • PHP125 Clinical Trial Learning Curves May Impact Both Clinical and Economic Outcomes, and Influence Health Technology Assessment and Reimbursement Decision Making

    Nov 1, 2011, 00:00

  • PMD46 Development of A Standard Reimbursement Dossier for the Evaluation of Effectiveness and Cost-Effectiveness of A New Medical Device (Nebulizer Mini-plus)

    Nov 1, 2011, 00:00

  • PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother- Estimating Cut-off Scores for Dry Eye Severity Groups

    Nov 1, 2011, 00:00

  • PND53 The Patient-Reported Burden of Impaired Walking in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PCN85 Cost-Effectiveness of A Human Papillomavirus Vaccination of Boys

    Nov 1, 2011, 00:00

  • PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States- Where are the Differences?

    Nov 1, 2011, 00:00

  • PSS24 Cost-Effectiveness of Ustekinumab vs Etanercept for Severe Psoriasis

    Nov 1, 2011, 00:00

  • PHP145 the Burden of Evidence in the Pharmaceutical Appraisal process

    Nov 1, 2011, 00:00

  • PRM34 Examining Variations in Item Structure and Content in Pro Instruments, or, There Must be 50 Ways to Express Your Distress

    Nov 1, 2011, 00:00

  • PND46 The Huntington Quality of Life Instrument (H-QOL-I)- Cross-Cultural Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PRS1 COST-Effectiveness Of Varenicline Versus Existing Smoking Cessation Strategies in Brazil from the Public Perspective, Using the Benesco Model

    Nov 1, 2011, 00:00

  • PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011

    Nov 1, 2011, 00:00

  • PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia- Analysis of Catie Data

    Nov 1, 2011, 00:00

  • PMD13 Cost Analysis of Vascular Closure Devices (VCD) in the United States

    Nov 1, 2011, 00:00

  • PHP9 Preditores Da quantidade De Medicamentos Tomados Em Pessoas Com DoenÇa Crónica

    Nov 1, 2011, 00:00

  • PCN198 Review of Economic Assessments of Emerging Genomic Technologies in Oncology

    Nov 1, 2011, 00:00

  • PRM15 The Outcome of ISPOR European and International Congresses Between 2005-2009

    Nov 1, 2011, 00:00

  • PHP1 Improving Patient Safety in the UK and Engaging Patients in research- A New Model for the NHS?

    Nov 1, 2011, 00:00

  • PDB42 Economic Evaluation of Recombinant Human FSH in Comparison with Urinary HMG in Assisted Reproduction in the Greek Setting

    Nov 1, 2011, 00:00

  • PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

    Nov 1, 2011, 00:00

  • MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data- An Efficient Use of Evidence for Cost-Effectiveness Modelling

    Nov 1, 2011, 00:00

  • PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea

    Nov 1, 2011, 00:00

  • PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

    Nov 1, 2011, 00:00

  • PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring Country

    Nov 1, 2011, 00:00

  • PSY13 Comparing Top Reasons for Primary Care or Specialty Care Visits Among Fibromyalgia Patients Initiated Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PHP160 Introducing the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)- A Bridge Between Medicines Regulation and Health Outcomes Research

    Nov 1, 2011, 00:00

  • PCV27 Frequency of Adverse Drugs Events (ADES) as Possible Causes of Request of Drugs Not Included in Essential Medicines List in Colombia

    Nov 1, 2011, 00:00

  • PHP107 Clinical Trial Activity in Gree Opportunities Missed, Soon to be Forgone?

    Nov 1, 2011, 00:00

  • PMD71 Resource Use Caused by in-office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PHP65 Pharmaceutical Expenditure in Portugal – Policies and Impact

    Nov 1, 2011, 00:00

  • PIH29 the Cost Effectiveness of Clinically Proven Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adult Patients

    Nov 1, 2011, 00:00

  • PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice

    Nov 1, 2011, 00:00

  • PCN105 Economic Evaluation of Panitumumab and Cetuximab in the Treatment of Patients with EGFR Expressing mCRC with Non-Mutated (Wild-Type) KRAS in Gree A Cost Minimization Analysis

    Nov 1, 2011, 00:00

  • PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment Tool

    Nov 1, 2011, 00:00

  • PCN153 Cost of Hospital Care in Population of Patients with Neoplasms in Poland

    Nov 1, 2011, 00:00

  • PMH20 Health Care Cost Comparisons between Alcohol or Opioid- Dependent Patients Who Were Treated with Medication and Those Who Were Not

    Nov 1, 2011, 00:00

  • PGI17 Cost of Outpatient Endoscopic Capsule (EC) Procedure in Brazil- A Study from a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PGI27 Sleep Disturbance and Quality of Life Among Hepatitis C Infected Individuals

    Nov 1, 2011, 00:00

  • PIN112 Use of Dynamic Models to Measure Health Outcomes of Pneumococcal Vaccination in Spanish Adult Population

    Nov 1, 2011, 00:00

  • PHP44 Inappropriate Prescriptions Based on Beers Criteria in Elderly Patients Treated at Home

    Nov 1, 2011, 00:00

  • PMD30 Cost-Effectiveness Analysis of Pulmonary Vein Isolation (PVI) Using A Novel Cryo Energy-Based Balloon Catheter- A High-Value procedure for Payers?

    Nov 1, 2011, 00:00

  • PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

    Nov 1, 2011, 00:00

  • PSS1 Evaluacion Economica De Fototerapia De Banda Angosta O Fotoquimioterapia Para El Tratamiento De Psoriasis Desde La Perspectiva Del Instituto Mexicano Del Seguro SOCIAL

    Nov 1, 2011, 00:00

  • PND44 Validation of the Fabry Outcome Survey (FOS) Paediatric Health and Pain Questionnaire

    Nov 1, 2011, 00:00

  • PIN109 Modelling the Policy of Managing Seasonal Influenza in the UK

    Nov 1, 2011, 00:00

  • PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)

    Nov 1, 2011, 00:00

  • PRM24 Scan- An Integrated System for Market Access of New Drugs in Italy

    Nov 1, 2011, 00:00

  • PSY6 Estudio De COSTO-Efectividad De Buprenorfina TRANSDÉrmica Versus Oxicodona Oral Y Fentanilo TRANSDÉrmico En El Manejo Del Dolor CRÓnico No OncolÓgico En El Hospital San JosÉ De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PIH19 Public Health Costs Associated with Outbreaks of Meningoccocal Disease- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN88 Economic Model of Granulocyte-Colony Stimulating Factor (G-CSF) in Primary (PP) and Secondary Prophylaxis (SP) of Febrile Neutropenia (FN) in Non-Hodgkin'S Lymphoma (NHL) Patients Undergoing Chemotherapy in France

    Nov 1, 2011, 00:00

  • PIN16 Rates and Predictors of Gonorrhea Re-Screening Among Privately Insured Patients with Gonorrhea in 2007-2009

    Nov 1, 2011, 00:00

  • CN2 Measuring Public Preferences For Colorectal Cancer Screening Using New Genome-Based Nanotechnologies

    Nov 1, 2011, 00:00

  • PMH79 The Impact of Comparative Effectiveness Research on Health and Health Care Spending

    Nov 1, 2011, 00:00

  • PIN90 Discrete Choice Experiments (DCES) in HIV/AIDS Treatment- Expert Judgement in Comparison to Patient Preferences

    Nov 1, 2011, 00:00

  • PMH14 Speed of Detection of Adverse Events in Spontaneous Adverse Event Databases Compared with Epidemiological Studies- Two related Cases

    Nov 1, 2011, 00:00

  • PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea

    Nov 1, 2011, 00:00

  • PHP110 Utilization of Physiotherapy Services in Hungary

    Nov 1, 2011, 00:00

  • PDB67 Treatment Patterns and Health Outcomes Among Type 2 Diabetes with Comorbid Obesity in France, Germany, And UK

    Nov 1, 2011, 00:00

  • PGI26 Evaluating the Impact of Gastrointestinal Episodes on the Health-related Quality of Life of Solid Organ Transplant Recipients- Validation of the SIGIT-QoL® Questionnaire – the Mypaciente 1 2 Studies

    Nov 1, 2011, 00:00

  • PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in Greece

    Nov 1, 2011, 00:00

  • PMS23 Analysis of Indirect Costs for Care of Rheumatoid Arthritis Patients Using Large Cohort Database, Iorra, in Japan

    Nov 1, 2011, 00:00

  • PSY35 Economic Evaluation of Darbepoetin Alfa in the Management of End Stage Renal Disease (ESRD) Patients with Anemia in the Greek Nhs Setting

    Nov 1, 2011, 00:00

  • PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

    Nov 1, 2011, 00:00

  • PRM3 Challenges to Obtain Real-Life Data in Observational Studies- What are the Solutions When the Patient is the Main Data Provider?

    Nov 1, 2011, 00:00

  • PND6 Outcomes of Antiepileptic Drugs Uses at Doses Above the Recommended Range Among Children with Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2011, 00:00

  • PDB73 Impact of Epidemiological and Economic Factors on Insulin Total Sales in the UK Diabetic Market

    Nov 1, 2011, 00:00

  • PCN194 The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies- The Case of Diabetes and Cancer Incidence

    Nov 1, 2011, 00:00

  • PUK3 COST-Effectiveness Of Anemia Treatment In Dialysis Patients In BRAZIL

    Nov 1, 2011, 00:00

  • PIH4 Analisis De Costo-Efectividad Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica

    Nov 1, 2011, 00:00

  • PCV105 Using Theory of Reasoned Action Variables to Predict and Improve Statin Adherence

    Nov 1, 2011, 00:00

  • PMS65 Quality of Life for Thai Hip Fracture Patients- Assessments with Medical outcomes Study, a 36-Item Short form Survey (MOS SF-36) and One-Year Health Care Resource Utilization in a Public Hospital

    Nov 1, 2011, 00:00

  • PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insurance

    Nov 1, 2011, 00:00

  • PMH43 Association Between Antidepressant-Related Weight Gain and Medication Adherence in Employed Individuals by Gender

    Nov 1, 2011, 00:00

  • PRS61 Age has No Significant Impact on Health-Related Quality of Life in Patients Hospitalized for COPD Exacerbations

    Nov 1, 2011, 00:00

  • DA2 A Choice that Matters- Comparing Methods of Data Synthesis in Cost-Effectiveness Modelling

    Nov 1, 2011, 00:00

  • PCV35 Safety and Tolerability of Bisoprolol Compared to Atenolol in Patients with Mild to Moderate Hypertension

    Nov 1, 2011, 00:00

  • PUK11 Preliminary Cost-Minimization Analysis of Continuous Versus Intermittent Renal Replacement Therapy in Intensive Care Patients Experiencing Acute Renal Failure

    Nov 1, 2011, 00:00

  • PSY42 Chronic Pain- Patient Treatment Preferences - a Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PIH3 Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)

    Nov 1, 2011, 00:00

  • PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PIN29 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus- A Cost Comparison Analysis Under the Private Payer Perspective in Brazil

    Nov 1, 2011, 00:00

  • PSY21 Predictors of Duloxetine Adherence and Persistence in Patients with Fibromyalgia

    Nov 1, 2011, 00:00

  • PMH24 Economic Burden of Mental Illnesses in Pakistan

    Nov 1, 2011, 00:00

  • PRS48 Cost-Utility Analysis of Varenicline vs Existing Smoking Cessation Strategies in EL Salvador

    Nov 1, 2011, 00:00

  • PIN88 Late Immunization Doses Received by Children Younger than Two Years

    Nov 1, 2011, 00:00

  • UT1 Combining DCE and TTO Into A Single Value Function

    Nov 1, 2011, 00:00

  • PIH32 What are the Factors Influencing Parental Apprehension About Consenting Children to Participate in Pediatric Observational Studies? A Survey Conducted in France with in Fine Pharma, a Pharmacist Network

    Nov 1, 2011, 00:00

  • PMD55 Resource Utilisation related to Urinary Tract infections in Swedish Self-Catheterisation Patients

    Nov 1, 2011, 00:00

  • PIH60 Changes in Blood Coagulation Properties Measured by Thrombelastometry During Spiroergometry in Sportsmen and in Sportswomen

    Nov 1, 2011, 00:00

  • PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in Greece

    Nov 1, 2011, 00:00

  • PRS28 Adherence to Current Guidelines for Chronic Obstructive Pulmonary Disease (COPD) in Subjects Treated with Combination of Long-Acting β2-Agonist (LABA), LONG-Acting Muscarinic Antagonist (LAMA) or Inhaled Corticosteroids (ICS)

    Nov 1, 2011, 00:00

  • PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxico

    Nov 1, 2011, 00:00

  • PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers Perspective

    Nov 1, 2011, 00:00

  • PCV84 Resource Utilization and Costs for Candesartan in Heart Failure- Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting

    Nov 1, 2011, 00:00

  • PIN52 Cost-Effectiveness of Rifampicin-Based Continuation Phase of Tuberculosis Treatment in Uganda

    Nov 1, 2011, 00:00

  • PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany

    Nov 1, 2011, 00:00

  • PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma- Results of the Apex Trial

    Nov 1, 2011, 00:00

  • PND22 A Cost-of-Illness Analysis of Myasthenia Gravis in Greece

    Nov 1, 2011, 00:00

  • PSS16 Cost of Blindness in Austria

    Nov 1, 2011, 00:00

  • PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

    Nov 1, 2011, 00:00

  • VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En Colombia

    Nov 1, 2011, 00:00

  • PMS7 The Osteoporotic Fracture Incidence in Elderly Women of Taiwan

    Nov 1, 2011, 00:00

  • PIN56 Cost-Effectiveness Model to Evaluate 200-Day vs 100-Day Treatment with Valganciclovir Prophylaxis to Reduce Cytomegalovirus Disease in High-Risk (D+/R-) Kidney Transplant Recipient in Spain

    Nov 1, 2011, 00:00

  • PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury- A Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PND48 Development of A Burden Questionnaire- Family Burden of Ichthyosis in Infants

    Nov 1, 2011, 00:00

  • PND28 Cost-Effectiveness Analysis of Interferons and Glatiramer Acetate as First Line Treatments in Remitting – Relapsing Multiple Sclerosis Spanish Patients

    Nov 1, 2011, 00:00

  • PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United States

    Nov 1, 2011, 00:00

  • PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey

    Nov 1, 2011, 00:00

  • PHP38 Health Technology Assessment Applied to Medical Devices in Latin America- What Must Be Assessed

    Nov 1, 2011, 00:00

  • PMS10 Cost-Effectiveness of Duloxetine Compared to Pregabaline in Patients with Fibromyalgia from the Public Health Care System perspective in México

    Nov 1, 2011, 00:00

  • PCN30 Comparative Analysis of Cost and Resource Use Among Patients With Brain Metastasis by Initial Primary Cancer

    Nov 1, 2011, 00:00

  • PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer

    Nov 1, 2011, 00:00

  • PMD60 Development and Content Validity of the COPD Device Preference Questionnaire

    Nov 1, 2011, 00:00

  • PCV21 Clinical Efficacy of Bisoprolol Compared to Atenolol in Reducing the In-Clinic and Ambulatory Blood Pressure in Hypertensive Patients

    Nov 1, 2011, 00:00

  • PIN4 Economic Impact Of Community Acquired Pneumonia Hospitalizations In Adults In Six Countries In Latin America

    Nov 1, 2011, 00:00

  • PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic Pain

    Nov 1, 2011, 00:00

  • PHP15 Price Negotiations in Korean Pharmaceutical Benefit System- How Compatible with CEA?

    Nov 1, 2011, 00:00

  • PDB7 Prevalence, Demographics and Treatment Characteristics of Diabetes with Lantus, NPH and Premix Insulin in a Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in Iran

    Nov 1, 2011, 00:00

  • PCN7 The Incidence and Outcome of Febrile Neutropenia in Different Chemotherapy Regimens for Cancer Patients in Belgium

    Nov 1, 2011, 00:00

  • PMH21 Economic Cost of Alcohol and Drug Abuse in Washington State, USA

    Nov 1, 2011, 00:00

  • PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM)- Case in Point Prostate Cancer

    Nov 1, 2011, 00:00

  • PSU3 Prevalence Rates of Surgical Complications Among Tuberous Sclerosis Complex Patients with Surgical Removal of Subependymal Giant Cell Astrocytoma- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PMD27 Cost-Effectiveness Analysis of Cardiac Resynchronization Therapy in Patients with Asymptomatic to Mild Heart Failure Based on the European Cohort of the reverse Study from the Spanish Health System Perspective

    Nov 1, 2011, 00:00

  • PHP58 Towards Cost-Effectiveness Analysis of the Health and Wellbeing Benefits of Urban Green Spa A Mapping Review

    Nov 1, 2011, 00:00

  • PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia- Using Outpatient Data from the REACH Registry

    Nov 1, 2011, 00:00

  • PHP12 Then and Now- The Evolution of International Reference Pricing Globally

    Nov 1, 2011, 00:00

  • PHP61 Modeling Pharmaceutical Costs in Primary Health Care According to Chronic Conditions

    Nov 1, 2011, 00:00

  • PRM62 The Impact of Centre Selection on the Generalisability of Economic Evaluation Results from Multi-Centre Randomised Controlled Trials

    Nov 1, 2011, 00:00

  • PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic Agents

    Nov 1, 2011, 00:00

  • PDB6 Description of Comorbidities and Body Mass Index in US Adults with and Without Diabetes from the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • MT3 A Bayesian Approach to Model Selection procedures within Mixed Treatment Comparison Framework

    Nov 1, 2011, 00:00

  • AD1 Compliance Measurement Using Administrative Data From German Sickness Funds

    Nov 1, 2011, 00:00

  • PRM25 Switch of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- The Development of a Flexible and Generic European Budget Impact Model

    Nov 1, 2011, 00:00

  • PSY55 Cost of Autologous and Allogeneic Stem Cell Transplantations for Haematological Disease- A Dutch Multicentre Daily Practice Study

    Nov 1, 2011, 00:00

  • PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration- A Systematic Review and Economic Evaluation

    Nov 1, 2011, 00:00

  • PIH2 Addressing Childhood Obesity In Mexico- Savings On Health Care Expenditures From Regulating Food And Beverage Sales In Basic Education Schools

    Nov 1, 2011, 00:00

  • PRS13 Specific Immunotherapy and the Economic Implications from the Perspective of German Statutory Health Insurance - a Budget-Impact Modeling Approach

    Nov 1, 2011, 00:00

  • PRS5 Cost-Effectiveness of Varenicline vs Existing Smoking Cessation Strategies in Dominican republic Using the Benesco Model

    Nov 1, 2011, 00:00

  • PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Results and Challenges

    Nov 1, 2011, 00:00

  • PHP70 Value Based Pricing (VBP)- Is This the Way Forward for the UK NHS?

    Nov 1, 2011, 00:00

  • PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PRM4 Measuring Comorbidity in Administrative Data

    Nov 1, 2011, 00:00

  • PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination- Findings from a Literature Review

    Nov 1, 2011, 00:00

  • PHP164 A Typology of Outcomes for Health Research

    Nov 1, 2011, 00:00

  • PMH18 The Economic and Social Consequences of Seroquel XR® (Quetiapine Prolonged Release Tablets) Reimbursement in Bipolar Disorder Treatment for Patients Currently Treated with Seroquel (Quetiapine Immediate Release Tablets) in Poland- Ana ...

    Nov 1, 2011, 00:00

  • PIN75 Cost-Effectiveness of Polysaccharide Pneumococcal Vaccination in People Aged 65 and Above in Poland

    Nov 1, 2011, 00:00

  • RM3 A Comparison Between Markov Chains and System Dynamics Modeling for the Estimation of Metabolic Syndrome Costs in a Public Health Care Delivery Organization in MÉxico

    Nov 1, 2011, 00:00

  • PSY43 The Translation and Linguistic Validation of the Treatment Related Impact Measure – Weight (Trim-Weight)

    Nov 1, 2011, 00:00

  • PMS57 Preliminary Psychometric Validation of the Sleep Disturbance and Sleep Adequacy Subscales of the 1-Week Recall Medical outcomes Study Sleep Scale in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PCN15 Dance as Physiotherapy in the Rehabilitation of Women Suffering from Tumour

    Nov 1, 2011, 00:00

  • PUK5 Mixed Treatment Comparisons of Immunosuppressants Following Renal Transplant

    Nov 1, 2011, 00:00

  • PIN23 To Assess or Not To Assess- That is the Question! Budget, Ethical and Decisional Impact assessment in HIV- Lombardy Region's Molo Project

    Nov 1, 2011, 00:00

  • PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil- Cost analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PIH52 Medicine Prescribing Patterns in HIV/AIDS and Non-HIV/AIDS Children- A Comparitive Study in the Private Health Care Sector of South Africa

    Nov 1, 2011, 00:00

  • PMD2 Clinical Decision Rules for Adults with Minor Head injury- A Systematic Review

    Nov 1, 2011, 00:00

  • PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies

    Nov 1, 2011, 00:00

  • HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion Mexicana

    Nov 1, 2011, 00:00

  • PDB9 Analisis De Costo–Efectividad Del Uso De Detemir En Diabetes Tipo 2 Frente Al Riesgo De Presentar Eventos Cardiovasculares Y Muerte

    Nov 1, 2011, 00:00

  • PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?

    Nov 1, 2011, 00:00

  • PHP8 ATC Classification and Its Role in Pricing Policies

    Nov 1, 2011, 00:00

  • PIH14 Rates and Predictors of Chlamydia re-Screening among Privately insured Patients with Chlamydia in 2007- 2009

    Nov 1, 2011, 00:00

  • PRS65 The Effect of Omalizumab on Unscheduled Healthcare Resource Utilisation and Health-Related Quality of Life in UK Clinical Practi The Apex Study

    Nov 1, 2011, 00:00

  • PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter

    Nov 1, 2011, 00:00

  • PRS8 Predicted Survival for North American Patients with Cystic Fibrosis Adjusted for Cohort Specific Covariates

    Nov 1, 2011, 00:00

  • PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics- The Case of Orphan Indications

    Nov 1, 2011, 00:00

  • MA4 Modelling EQ-5D Health State Values- Developing A Limited Dependent Variable, Mixture Modeling Approach

    Nov 1, 2011, 00:00

  • PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia

    Nov 1, 2011, 00:00

  • PRS42 Pharmacoeconomic Analysis of Methylprednisolone Aceponate for Treatment of Atopic Dermatitis and Eczema

    Nov 1, 2011, 00:00

  • PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov Model

    Nov 1, 2011, 00:00

  • PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

    Nov 1, 2011, 00:00

  • PHP96 Mitigating Emergency Department Over-Crowding Utilizing Focused Operations Management Tools

    Nov 1, 2011, 00:00

  • NI4 The Association between Financial Impact and the likelihood of recommendation of Medicines for Use in England and Wales

    Nov 1, 2011, 00:00

  • PIN10 Clinical and Economic Burden of Hospital Onset Health Care Facility Acquired Clostridium Difficile Infection (HO-HCFA-CDI) in Europe- A Systematic Review

    Nov 1, 2011, 00:00

  • PRS56 Assessing Patient Report of Function- Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary Disease

    Nov 1, 2011, 00:00

  • PDB75 Analysis of the Medicines Pricing Procedure in the Republic of Macedonia

    Nov 1, 2011, 00:00

  • PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative Colitis

    Nov 1, 2011, 00:00

  • PSY40 Eq-5D Utilities in Patients with Chronic Pain Due to Osteoarthritis of the Knee or Low Back Pain Treated with Tapentadol and Oxycodone

    Nov 1, 2011, 00:00

  • HG4 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis- Theoretical Framework and Application

    Nov 1, 2011, 00:00

  • PND2 Cost Offsets and Gains in Health Effects in the Treatment of Relapsing–Remitting Multiple Sclerosis with Laquinimod- An Analysis Based on the Allegro Trial

    Nov 1, 2011, 00:00

  • PSY26 Cost Benefit Analysis of a Worksite Weight Management Program

    Nov 1, 2011, 00:00

  • PHP34 Necesidades De información Y formación Sobre Farmacoeconomia E Investigación De Resultados Para Profesionales Y Estudiantes De Farmacia Del Oriente Venezolano

    Nov 1, 2011, 00:00

  • PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in Brazil

    Nov 1, 2011, 00:00

  • PCV137 The Impact of Dementia on Care Patterns After Discharge for Acute Coronary Syndromes Under National Health Insurance System

    Nov 1, 2011, 00:00

  • PMH32 Cost-Effectiveness of Agomelatine in the Treatment of Major Depressive Episodes in Thailand

    Nov 1, 2011, 00:00

  • PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care Plan

    Nov 1, 2011, 00:00

  • PHP67 Tendering for Outpatient Prescription Pharmaceuticals- What Can Be Learned from Current Practices in Europe?

    Nov 1, 2011, 00:00

  • PRM37 Assessing the Health Status of Roma Population by Using SF-36 Health Survey- Evidence from Greece

    Nov 1, 2011, 00:00

  • PHP51 Pill Burden in South African Patients With Multiple Risk Factors for Metabolic Syndrome

    Nov 1, 2011, 00:00

  • PIH62 Comparative Pricing and Reimbursement Analysis in Four East European Countries

    Nov 1, 2011, 00:00

  • PRS75 Health Technology Appraisal of New Drugs- Are we Getting it Right?

    Nov 1, 2011, 00:00

  • PIH8 Impact Assessment of Sport- Recreation Training

    Nov 1, 2011, 00:00

  • PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis

    Nov 1, 2011, 00:00

  • PHP133 Levels of Population Risk Stratification Based on the Cost of Care in Patients with Chronic Diseases

    Nov 1, 2011, 00:00

  • PMD52 Workload in German Hospitals Caused by Routine Follow-up Services for Cardiac Implantable Electrical Devices (CIED)

    Nov 1, 2011, 00:00

  • PRM59 Estimating the Confidence Interval for the Cost-Effectiveness Ratio from A Family of Regressions on Net Monetary Benefit

    Nov 1, 2011, 00:00

  • PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2011, 00:00

  • PMD78 Benefit-Risk Analysis in Absence of Clinical Eviden Deciding for Treatment of Skull Deformity in Babies Aged 5 Months

    Nov 1, 2011, 00:00

  • PSY3 The Potential Impact of Obesity Degree on Diabetes, Heart Attack, Hypertension, Chronic Anxiety and Depression in Adult Spanish Population

    Nov 1, 2011, 00:00

  • PCN130 Utility Weights for Skeletal Related Events in Castration Resistant Prostate Cancer

    Nov 1, 2011, 00:00

  • PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PGI16 Comparison of Treatment and Indirect Costs Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PHP81 Funding Sources Analysis Results (Regional and Federal Levels) of Pharmaceutical Markets per Regions of Russian Federation

    Nov 1, 2011, 00:00

  • PND47 The Huntington Clinical Self-Reported Instrument (H-CSRI)- Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PHP2 Relation Between Consumer Behaviour and Drug Safety Monitoring in France

    Nov 1, 2011, 00:00

  • PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study

    Nov 1, 2011, 00:00

  • PMS60 Experiences of Patients with Rheumatoid Arthritis in the US and UK- A Cross-Cultural Comparison

    Nov 1, 2011, 00:00

  • PIN77 Cost Effectiveness of De-Escalation from Micafungin in the Treatment of Patients with Systemic Candida Infections Compared to Traditional Escalation from Fluconazole

    Nov 1, 2011, 00:00

  • PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the Netherlands

    Nov 1, 2011, 00:00

  • PDB76 Knowledge, Medication Adherence and Glycemic Control Among Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PGI3 AdaptaciÓn De Un ANÁlisis De Costo-Efectividad Del Entecavir vs InterferÓn Pegilado Alfa a Venezuela

    Nov 1, 2011, 00:00

  • PIH46 Satisfaction with Prescription and Over-the-Counter Medications- Results from a Novel Patient Registry

    Nov 1, 2011, 00:00

  • PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany

    Nov 1, 2011, 00:00

  • PHP71 Effect of SIADH on Patient outcomes and Health Care Resource Utilization in Hospitalized Patients

    Nov 1, 2011, 00:00

  • PMD77 Components of Health Technology Assessment for Radiology in Chile

    Nov 1, 2011, 00:00

  • PCN141 Quality of Life in Small Cell Lung Cancer- Results of an Open-Label Phase III Clinical Trial

    Nov 1, 2011, 00:00

  • PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMS38 A Structured Literature Review of Rheumatoid Arthritis Economic Models for Biologics

    Nov 1, 2011, 00:00

  • PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill Patients

    Nov 1, 2011, 00:00

  • PHP19 Increased Market Share of Private, For-Profit Health Care Providers From the Hungarian Health Insurance Budget Between 2006-2009

    Nov 1, 2011, 00:00

  • ISPOR 14th annual European congress financial disclosure information for research presetnations

    Nov 1, 2011, 00:00

  • PGI8 Cost Analysis and Incidence of Adverse Gastrointestinal Events Following Bisphosphonate Treatment Among Women with Osteoporosis in Taiwan

    Nov 1, 2011, 00:00

  • PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in Poland

    Nov 1, 2011, 00:00

  • PCV74 Is Treatment of Depression Cost Effective in the Management of People with CHD and Diabetes- A Systematic Review of the Economic Evidence

    Nov 1, 2011, 00:00

  • PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

    Nov 1, 2011, 00:00

  • PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin America

    Nov 1, 2011, 00:00

  • PCN21 Systematic Review of Skeletal Related Events in Prostate Cancer

    Nov 1, 2011, 00:00

  • PCV132 Do Atrial Fibrillation (AF) Patients Get Oral Anticoagulation (OAC) as Guidelines Recom-Mend? An Analysis of German Health Insurance Claims Data

    Nov 1, 2011, 00:00

  • PGI1 Resource Utilization and Cost of Management of Complex Perianal Fistula in Crohn's Disease in Spain

    Nov 1, 2011, 00:00

  • PMD58 Provision and Financing of Medical Aids in the Management of Rare Diseases- The Case of Amyotrophic Lateral Sclerosis (ALS)

    Nov 1, 2011, 00:00

  • PCN189 The Use of Parametric Survival Analysis to Predict Progression Free and Overall Survival of Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients

    Nov 1, 2011, 00:00

  • DA4 Finding Treatment Effects within Subgroups when Using the propensity Score to Control for Selection Bias- A Monte Carlo Simulation Study

    Nov 1, 2011, 00:00

  • PMS66 Conceptual Model of the Impact of Hip Fracture on Patients' Lives

    Nov 1, 2011, 00:00

  • PIN11 Evaluacion Economica De Las Vacunas Conjugadas De Pneumococo Para Peru

    Nov 1, 2011, 00:00

  • PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology Drugs

    Nov 1, 2011, 00:00

  • PCV41 The Budgetary Impact of Implementing A Telehealth Home Monitoring System for Chronic Heart Failure Patients in a Typical UK Primary Care Trust

    Nov 1, 2011, 00:00

  • PMS26 Cost of Dupuytren Contracture in the Czech Republic

    Nov 1, 2011, 00:00

  • PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared with 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada

    Nov 1, 2011, 00:00

  • PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato Trial

    Nov 1, 2011, 00:00

  • PSY23 Pregabalin is Associated with Lower Health Care Costs and Less Absenteeism than Gabapentin when Added to the Treatment of Neuropathic Pain

    Nov 1, 2011, 00:00

  • PRM44 The First Research- Assessment of the WTP Threshold for QALY by Contingent Valuation Method in Russia

    Nov 1, 2011, 00:00

  • PIN65 Health Economic Model on the Costs and Effects of Rota Virus Vaccination in Germany

    Nov 1, 2011, 00:00

  • PSY3 Use Of A Discrete Event Simulation Model To Estimate Long Term Economic Outcomes Of Bariatric Surgery In Morbidly-Obese, Type-2 Diabetic Patients In Mexico

    Nov 1, 2011, 00:00

  • PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En Colombia

    Nov 1, 2011, 00:00

  • PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and Manufacturers

    Nov 1, 2011, 00:00

  • PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

    Nov 1, 2011, 00:00

  • PHP93 Regional Differences among Methadone Maintenance Programs in Spain

    Nov 1, 2011, 00:00

  • PCN143 Electronic Patient-Reported Outcome Monitoring in Testicular Cancer Patients

    Nov 1, 2011, 00:00

  • HT2 Value Based Pricing- One Threshold too Far for the United Kingdom

    Nov 1, 2011, 00:00

  • PND38 International Comparison of Huntington Disease (HD) Burden

    Nov 1, 2011, 00:00

  • PCV73 Cost Effectiveness of Speech and Language Therapy Following Stroke

    Nov 1, 2011, 00:00

  • PSS20 Annual Cost of Biological Therapies for the Treatment of Moderate to Severe Plaque Psoriasis in Spain

    Nov 1, 2011, 00:00

  • PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

    Nov 1, 2011, 00:00

  • PMS64 Sensitivity of Pro'S to Detect Changes in Quality of Life in Patients Treated with a Biologic Agent

    Nov 1, 2011, 00:00

  • PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for Argentina

    Nov 1, 2011, 00:00

  • PCN92 The Cost-Effectiveness of Nanoparticle Albumin-Bound Paclitaxel Compared to Solvent-Based Paclitaxel in Women with Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PGI22 The Extra Health Care Costs Associated Withantimicrobial Prophylaxis in Colorectal Surgical Patients- An Exploration of Profiling Data from a University Hospital in Japan

    Nov 1, 2011, 00:00

  • PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PHP162 Impact of AMNOG on Pharmaceutical Pricing Trends in Germany

    Nov 1, 2011, 00:00

  • PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO

    Nov 1, 2011, 00:00

  • PDB11 Economic Evaluation of Teripatide in the Management of Women with Postmenopausal Osteoporosis and High Risk of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)

    Nov 1, 2011, 00:00

  • PSS6 Epidemiology, Disease Burden, Symptomatology, Treatment Pattern, and Quality of Life in Macular Degeneration in Korea- Systematic Literature Review Based on Korean Evidence

    Nov 1, 2011, 00:00

  • PHP13 A Survey of Pricing Trends Around the World

    Nov 1, 2011, 00:00

  • PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom

    Nov 1, 2011, 00:00

  • PND10 Budget Impact Analysis of the Introduction of Fampridine to Improve Ambulation in Patients with Multiple Sclerosis (MS) in the UK

    Nov 1, 2011, 00:00

  • PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal Settings

    Nov 1, 2011, 00:00

  • PIN40 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus- A Cost Comparison Analysis Under the Public Hospital Perspective in Brazil

    Nov 1, 2011, 00:00

  • PND13 Management of Focal Epilepsy Treated by Polytherapy in Fran The Cost of Pharmaco-Resistance

    Nov 1, 2011, 00:00

  • PIN85 Costs of Influenza and Influenza Like Illness from the Employer's Perspective in Poland

    Nov 1, 2011, 00:00

  • PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain

    Nov 1, 2011, 00:00

  • PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages- Results From an Observational Study

    Nov 1, 2011, 00:00

  • PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of Pertussis

    Nov 1, 2011, 00:00

  • PND59 A Common Road Map for Rational Clinical and Policy Decisionmaking- Application of the MCDA-Based Evidem Framework to Growth Hormone Use in Patients with Prader-Willi Syndrome

    Nov 1, 2011, 00:00

  • PDB6 Educational Interventions in Patients with Type-2 Diabetes Improve Clinical and Metabolic Outcomes and Optimize the Use of Treatment Resources in Argentina- The Prodiacor Study

    Nov 1, 2011, 00:00

  • PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)- Economic Modeling (EM) results

    Nov 1, 2011, 00:00

  • PCN173 Cancer Incidence Evaluation and Pathway Identification for Treatment Course Detection Using Billing Data for Austria

    Nov 1, 2011, 00:00

  • PHP154 Iranian Health System Decentralization Reform- A Qualitative Study of Various Levels of Autonomy Granted to Public Hospitals Affilieated with Ministry of Health in Iran

    Nov 1, 2011, 00:00

  • PHP129 Societal Preferences for Health Technology Disinvestment Policy- Views of Scottish Taxpayers – A Qualitative Study

    Nov 1, 2011, 00:00

  • PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017

    Nov 1, 2011, 00:00

  • PSU13 Healthcare Resources Utilization and Associated Costs with Surgical Treatment of Dupuytrenxs Disease in Spain

    Nov 1, 2011, 00:00

  • PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in Russia

    Nov 1, 2011, 00:00

  • PHP46 Market Uptake of Orphan Drugs – A European Analysis

    Nov 1, 2011, 00:00

  • PMS22 The Burden of Illness of Osteoporosis in Canada

    Nov 1, 2011, 00:00

  • PRM19 Modelling the Impact of Multiple Indication Drug Launch on Total Revenue

    Nov 1, 2011, 00:00

  • PDB64 Criteria for Referral of Type 2 Diabetes Patients from Primary Care to Specialized Care and Vice Versa in Spain. Pathways Study

    Nov 1, 2011, 00:00

  • PRM6 Validating an Alternative Weighting Algorithm of the Charlson Comorbidity Index (CCI) for Risk Adjustment in Previously Hospitalized Patients

    Nov 1, 2011, 00:00

  • PSY50 Managing Pain Management- A Public Health Challenge

    Nov 1, 2011, 00:00

  • PND12 the Cost of Corticosteroid-associated Adverse Events in Systemic Lupus Erythematosus

    Nov 1, 2011, 00:00

  • PDB3 Prevalence of Severe Osteoporosis in Daily Consultation of Rheumatology and Endocrinology Services, Costs and Quality of Life of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • PHP4 Significant Decrease in the Hungarian Health Insurance Pharmaceutical Budget Between 2006-2009

    Nov 1, 2011, 00:00

  • PND39 Hereditary Angioedema Health State Utility Valuation Study from the Perspective of A Representative Sample of the Australian General Public

    Nov 1, 2011, 00:00

  • PMH74 Impact of Age and Gender in the Pharmaceutical Expenditure of Anxiolytics in Primary Health Care

    Nov 1, 2011, 00:00

  • PHP117 The Cost-Effectiveness Threshold- The Results of A Novel Literature Review Method

    Nov 1, 2011, 00:00

  • PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK

    Nov 1, 2011, 00:00

  • PIH49 Otis- An Aid Tool for the Management of Itchy Scalps

    Nov 1, 2011, 00:00

  • PHP41 Monitoring of HPV Vaccination Effectiveness Within European Union

    Nov 1, 2011, 00:00

  • PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)

    Nov 1, 2011, 00:00

  • PIN13 Epidemiology of Staphylococcus Aureus Infections in Children- A Literature Review of the Last 10 Years

    Nov 1, 2011, 00:00

  • RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos Neonatales

    Nov 1, 2011, 00:00

  • PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European Countries

    Nov 1, 2011, 00:00

  • PCV123 The Participation Decision for Lifestyle Disease Screening

    Nov 1, 2011, 00:00

  • UT3 The Validity Of The EQ-5D, SF-6D, SF-36 and SF-12 In Mental Health Conditions- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN184 Trends in Chemotherapy and Biologic Treatment of US Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PHP137 Guidelines for Pharmacoeconomic Evaluation for Serbia

    Nov 1, 2011, 00:00

  • PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting

    Nov 1, 2011, 00:00

  • PCV46 Clinical and Economic Burden of Major Bleeding in Abdominal Surgery Patients

    Nov 1, 2011, 00:00

  • PHP9 Temporary Use Authorizations- The Economic and Clinical Future of Drugs Used in the French Compassionate Program

    Nov 1, 2011, 00:00

  • PRM68 Outcome Measures Hierarchy for Attention-Deficit Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PSY12 Comparison of the Most Common Reasons for Inpatient Admissions Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PMS27 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporosis Treatment of Patients Without Fractures in Slovenia, Serbia, Slovakia and Bulgaria

    Nov 1, 2011, 00:00

  • PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?

    Nov 1, 2011, 00:00

  • PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain

    Nov 1, 2011, 00:00

  • PHP141 In Search of Reform for the Greek Health Care System- Depicting the Key Opinion Leaders' Views

    Nov 1, 2011, 00:00

  • PHP1 Kenya'S Village Aging insensitivity to Aging Policies

    Nov 1, 2011, 00:00

  • PIN2 Facing Critical Health Events- Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010

    Nov 1, 2011, 00:00

  • PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in Europe

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124 (current)
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »